Skip to search formSkip to main contentSkip to account menu

medorinone

Known as: 5-methyl-1,6-naphthyridin-2(1H)-one 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Naphthyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Electric field mapping and structure-activity relationship for cardiotonic activities of medorinone and some of its analogs.
Medorinone 5-methyl-1,6-napthyridin-2(1H)-one and some of its analogs having varying degrees of cardiotonic potency have been… 
1997
1997
Electric field mapping and structure-activity relationship for cardiotonic activities of medorinone and some of its analogs.
Medorinone 5-methyl-1,6-napthyridin-2(1H)-one and some of its analogs having varying degrees of cardiotonic potency have been… 
1992
1992
Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.
Two series of medorinone (3) analogs were prepared by modifications at C(2) and C(5). The C(2)-series was prepared from 2-chloro… 
1990
1990
Cardiovascular effects of medorinone in β‐adrenoreceptor‐blocked and non‐blocked anesthetized dogs
The hemodynamic effects of the low Km cAMP peak III PDE inhibitor medorinone (0.01–0.3 mg/kg, i. v. ) were evaluated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)